Endothelium/vascular type/nitric oxide

Citations 31-40 of 1031 total displayed.

Past content (since Jan 1999):

Brief Reviews
Unveiling the Role of Multidrug Resistance Proteins in Hypertension

João Marcos A. Delou, Aníbal G. Lopes, and Márcia A.M. Capella
Hypertension 2009;54:210-216; published online before print as doi:10.1161/HYPERTENSIONAHA.109.129742 [Full text]  

Editorial Commentaries
Have No Fear, MitoQ₁₀ Is Here

John C. Barbato
Hypertension 2009;54:222-223; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135533 [Full text]  

Editorial Commentaries
Mitochondrial Thioredoxin: Novel Regulator for NADPH Oxidase and Angiotensin II-Induced Hypertension

Tohru Fukai
Hypertension 2009;54:224-225; published online before print as doi:10.1161/HYPERTENSIONAHA.109.134403 [Full text]  

Original Articles
Impact of Shear Rate Modulation on Vascular Function in Humans

Toni M. Tinken, Dick H.J. Thijssen, Nicola Hopkins, Mark A. Black, Ellen A. Dawson, Christopher T. Minson, Sean C. Newcomer, M. Harold Laughlin, N. Timothy Cable, and Daniel J. Green
Hypertension 2009;54:278-285; published online before print as doi:10.1161/HYPERTENSIONAHA.109.134361 [Abstract] [Full text]  

Original Articles
Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile

Ngan N. Huynh, Karen L. Andrews, Geoffrey A. Head, Sacha M.L. Khong, Dmitry N. Mayorov, Andrew J. Murphy, Gavin Lambert, Helen Kiriazis, Qi Xu, Xiao-Jun Du, and Jaye P.F. Chin-Dusting
Hypertension 2009;54:294-301; published online before print as doi:10.1161/HYPERTENSIONAHA.108.121731 [Abstract] [Full text]  

Original Articles
Estrous Cycle–Dependent Neurovascular Dysfunction Induced by Angiotensin II in the Mouse Neocortex

Carmen Capone, Josef Anrather, Teresa A. Milner, and Costantino Iadecola
Hypertension 2009;54:302-307; published online before print as doi:10.1161/HYPERTENSIONAHA.109.133249 [Abstract] [Full text]  

Original Articles
Mitochondria-Targeted Antioxidant MitoQ₁₀ Improves Endothelial Function and Attenuates Cardiac Hypertrophy

Delyth Graham, Ngan N. Huynh, Carlene A. Hamilton, Elisabeth Beattie, Robin A.J. Smith, Helena M. Cochemé, Michael P. Murphy, and Anna F. Dominiczak
Hypertension 2009;54:322-328; published online before print as doi:10.1161/HYPERTENSIONAHA.109.130351 [Abstract] [Full text]  

Original Articles
Attenuation of Angiotensin II–Induced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2

Julian D. Widder, Daniela Fraccarollo, Paolo Galuppo, Jason M. Hansen, Dean P. Jones, Georg Ertl, and Johann Bauersachs
Hypertension 2009;54:338-344; published online before print as doi:10.1161/HYPERTENSIONAHA.108.127928 [Abstract] [Full text]  

Original Articles
Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization

Sarah K. Walsh, Fred A. English, Edward J. Johns, and Louise C. Kenny
Hypertension 2009;54:345-351; published online before print as doi:10.1161/HYPERTENSIONAHA.109.132191 [Abstract] [Full text]  

Original Articles
Direct Chronic Effect of Steroid Hormones in Attenuating Uterine Arterial Myogenic Tone: Role of Protein Kinase C/Extracellular Signal–Regulated Kinase 1/2

Daliao Xiao, Xiaohui Huang, Shumei Yang, and Lubo Zhang
Hypertension 2009;54:352-358; published online before print as doi:10.1161/HYPERTENSIONAHA.109.130781 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104